講演・口頭発表等 - 大川　龍之介

分割表示  294 件中 1 - 20 件目  ／  全件表示 >>

  1. Akiyama H., Miyakoshi T., Yoshimoto A., Watanabe M., Ichimura N., Tohda S., Ohkawa R.. Impact of Efflux Duration on Cholesterol Efflux Capacity in Cellular Assays.. Association for Diagnostics & Laboratory Medicine (ADLM) 2025 2025.07.29 Chicago

  2. 70. Izumi.S., Miyakoshi.T., Kawaguchi.R., Yoshimoto.A., Tozuka.M., Ohkawa.R.. Influence of different apolipoprotein B-depleted serum preparation methods on high-density lipoprotein cholesterol efflux capacity assays.. Association for Diagnostics & Laboratory Medicine (ADLM) 2025 2025.07.29 Chicago

  3. Izumi S., Miyakoshi T., Kawaguchi R., Yoshimoto A., Tozuka M., Ohkawa R. Impact of BDS preparation methods on HDL cholesterol efflux capacity assays: advantages of a cell-Free ILG method. 47th The Association of Medical Technologist of Thailand (ACMTT) 2025 2025.05.29

  4. Nobuharu Suzuki, Hinako Saito, Riko Takahashi, Nanako Yamada, Mio Fujisato, Kanoko Mitsunari, Binri Sasaki, Yukina Hosoda, Chikako Hayashi, Toru Doi, Mikael Simons, and Ryunosuke Ohkawa. The maintenance of small diameter axons after dysmyelination in teneurin-4 deficient mice. . CELL BIO24 (An ASCB/EMBO Meeting) 2024.12.15 San Diego, CA, US.

  5. Ohkawa R. Tips for identifying and managing abnormal reaction curves. 17th Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) Congress 2024.11.03 Sydney

  6. Someya Y., Shibuya M., Sun C., Yamazaki A., Miyakoshi T., Kawaguchi R., Yoshimoto A., Ohkawa R.. Establishment of a method for measuring apolipoproteins transfer rates between high-density lipoprotein and very lowdensity lipoprotein by ELISA. 17th Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) Congress 2024.11.01 Sydney

  7. Yamazaki A., Yoshimoto A., Ichimura N., Tohda S., Ohkawa R. Validation and Application of Direct Measurement Method for Erythrocytes Cholesterol Content. 17th Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) Congress 2024.11.01 Sydney

  8. Akiyama H., Miyakoshi T., Kawaguchi R., Kameda T., Yoshimoto A., Ohkawa R. Effect of Cholesterol Loading on the Assay for ABCA1-mediated Cholesterol Efflux Capacity using THP-1 cells and BODIPY-cholesterol. 17th Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) Congress 2024.11.01 Sydney

  9. Ohkawa R.. How Should We Evaluate High-Density Lipoprotein?. International Medini Healthcare Conference 2024 In conjunction with MIMLS 33rd National Scientific Conference 2024.09.24 Johor Bahru

  10. Ohkawa R. High-density lipoprotein - small particles with a big impact -. The 46th Annual Conference of The Association of Medical Technologists of Thailand (ACMTT) 2024.06.13 Bangkok

  11. Miyakoshi T., Akiyama H, Horiuchi Y., Araki M., Yonetsu T., Yoshimoto A., Tozuka M., Sasano T., Ohkawa R. Comparison of clinical usefulness of CEC assays by immobilized liposome-bound magnetic beads method and conventional cell-dependent assay targeting at coronary artery plaque size. European Atherosclerosis Society (EAS) 92nd Congress 2024.05.27 Lyon

  12. Yamazaki A., Yokoyama S., Okazaki M., Ai M., Miyake S., Takahashi J., Kameda T., Ichimura N., Tohda S., Ohkawa R. Influence of lipoprotein(a) on the accuracy of LDL-cholesterol measurement. European Atherosclerosis Society 92nd Congress 2024.05.27 Lyon

  13. Kawaguchi R., Yoshimoto A., Kameda T., Ohkawa R. Serum Analysis, not Isolated HDL Analysis, Reveals a New Effect of Homocysteine Modification on HDL Paraoxonase 1 Activities and Distribution. European Atherosclerosis Society (EAS) 92nd Congress 2024.05.27 Lyon

  14. Hinako Saito, Riko Takahashi, Mio Fujisato, Yukina Hosoda, Chikako Hayashi, Ryunosuke Ohkawa, and Nobuharu Suzuki. The molecular mechanism of axon maintenance after myelination defect. 第46回日本分子生物学会年会 2023.12.08

  15. Miyakoshi T., Horiuchi Y., Araki M., Yonetsu T., Watanabe M., Nakamura M., Kameda T., Yoshimoto A., Ichimura N., Tohda S., Tozuka M., Sasano T., Ohkawa R. Association between CEC measured by immobilized liposome-bound gel beads method and the size of lipid-rich coronary artery plaque. Scientific Session of the American Heart Association 2023.11.09 Philadelphia

  16. Horiuchi Y., Kameda T., Ogura M., Miida T., Tozuka M., Ohkawa R. Search for standardizable references in cell-free cholesterol efflux assay using immobilized liposome-bound gel beads. the 12th International Congress on Lipid & Atherosclerosis with Asia-Australia Vascular Biology Meeting (ICoLA 2023 in conjunction with AAVBM) 2023.09.15 Seoul

  17. Ohkawa R.. Structural and Functional Analysis of Modified HDL. Lunchtime Seminar at Chulalongkorn University 2023.08.18 Bangkok

  18. Miyakoshi T., Mutsuda Y., Horiuchi Y., Kameda T., Tozuka M., Ohkawa R. Application of bilirubin oxidase for improvement of false positive error caused by bilirubin on cholesterol efflux capacity assay by immobilize liposome-bound gel beads method. American Association for Clinical Chemistry (AACC) 2023 AACC Annual Scientific Meeting & Clinical Lab Expo 2023.07.24 Anaheim

  19. Yamazaki A., Nukui Y., Kameda T., Saito R., Koda Y., Ichimura N., Tohda S., Ohkawa R.. Usefulness of presepsin and thrombomodulin measurements for predicting COVID-19 mortality. American Association for Clinical Chemistry (AACC) 2023 AACC Annual Scientific Meeting & Clinical Lab Expo 2023.07.24 Anaheim

  20. Mikame M., Tsuno N.H., Miura Y., Kitazaki H., Uchimura D., Miyagi T., Miyazaki T., Onodera T., Ohashi W., Kameda T., Ohkawa R., Kino S., Muroi K. Correlation of ABO antibody titers with physiological/biochemical parameters in Japanese blood donors, and comparison between donors of 2010 and 2021. 33rd Regional Congress of the ISBT 2023.06.17 Gothenburg

< 前のページ - 次のページ >

このページの先頭へ▲